Cardiovascular Systems Reports Fiscal First-Quarter 2010 Financial Results

Posted by Dana in November 5th 2009

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, reported financial results for its fiscal first quarter ended September 30, 2009.

Cardiovascular Systems to Webcast Fiscal 2010 First-Quarter Earnings Conference Call Wednesday, November 4

Posted by Dana in October 31st 2009

Cardiovascular Systems, Inc. (CSI) (Nasdaq:CSII) will host a live webcast of its fiscal 2010 first-quarter conference call on Wednesday, November 4, 2009, at 3:45 p.m. CT (4:45 p.m. ET). David L. Martin, president and chief executive officer, and Laurence L. Betterley, chief financial officer, will discuss the company’s results for the fiscal first quarter ended [...]

Continue reading " Cardiovascular Systems to Webcast Fiscal 2010 First-Quarter Earnings Conference Call Wednesday, November 4 "

No Comment

under: General
Tags: cardiovascular, conference, financial, Systems

Cardiovascular Systems Reports Fiscal Fourth-Quarter and Full-Fiscal 2009 Financial Results

Posted by Dana in August 20th 2009

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fourth quarter and fiscal year ended June 30, 2009.

Cardiovascular Systems to Webcast Fiscal Fourth-Quarter and Full-Year 2009 Earnings Conference Call Wednesday, August 19

Posted by Dana in August 14th 2009

Cardiovascular Systems, Inc. (CSI)(Nasdaq: CSII) will host a live webcast of its fiscal fourth-quarter and full-year conference call on Wednesday, August 19, 2009, at 4 p.m. CT (5 p.m. ET). David L. Martin, president and chief executive officer of CSI, and Laurence L. Betterley, chief financial officer, will discuss the company’s results for the fiscal [...]

Continue reading " Cardiovascular Systems to Webcast Fiscal Fourth-Quarter and Full-Year 2009 Earnings Conference Call Wednesday, August 19 "

No Comment

under: General
Tags: call, cardiovascular, conference, Systems

Oscient Pharmaceuticals Discontinues Sales Force Promotion for ANTARA and FACTIVE

Posted by Dana in June 15th 2009

Oscient Pharmaceuticals Corporation (NASDAQ: OSCI) announced that it will discontinue sales force promotion of its two products: ANTARA (fenofibrate) capsules, a cardiovascular product and FACTIVE (gemifloxacin mesylate) tablets, a fluoroquinolone antibiotic.